CCR presentations at AACR 2020


The AACR Virtual Annual Meeting Session II will take place June 22-24. Please visit https://www.aacr.org/meeting/aacr-annual-meeting-2020/coronavirus-information/ for more information.

A number of CCR scientists will present their research at the AACR Annual Meeting. Selected oral presentations are listed below. 
 

Monday, June 22, 2020

Time Title Presenter/Authors Session
 9:00 AM - 6:00 PM Poster #3898 / 17 - Loss of polycomb repressive complex 2 activates HOXB8 and remodels super enhancers in malignant peripheral nerve sheath tumors Xiyuan Zhang, Ph.D., Pediatric Oncology Branch (Women in Cancer Research Scholar Award) PO.TB08.02 - Mechanisms and Modifiers of Driver Oncogenes and Epigenetic Regulators in Pediatric Malignancies

Tuesday, June 23, 2020

Time Title Presenter/Authors Session
9:05 AM - 9:15 AM 5694 - Complete regression of murine breast tumors by hetIL-15FC monotherapy correlates with infiltration by T, NK, cDC1 cells and a novel population of dendritic cells Dimitris Stellas, Ph.D., Vaccine Branch MS.IM02.04 - Novel Immunotherapies and Mechanisms
9:35 AM - 9:45 AM 1068 - Tumor infiltrating lymphocytes (TIL) recognize a unique and diverse number of non-synonymous somatic mutations in patients with metastatic breast cancer Nikolaos Zacharakis, Ph.D., Surgery Branch MS.IM02.01 - Adoptive Cell Therapy
10:05 AM - 10:15 AM 1110 - A novel peptide based microRNA nanoparticle hydrogel composite attenuates mesothelioma growth Anand Singh, Ph.D., Thoracic Surgery Branch MS.TB04.01 - Metastatic Mechanisms: New Insights
10:35 AM - 10:45 AM 5714 - Targeting serine metabolism impairs tumor growth in preclinical models of Ewing sarcoma Sameer H. Issaq, Ph.D., Urologic Oncology Branch MS.MCB08.01 - Metabolism and Cancer
5:15 PM - 6:00 PM Awardee, AACR Distinguished Public Service Award Doug Lowy, M.D., Laboratory of Cellular Oncology LE17 - AACR Distinguished Public Service Award

Wednesday, June 24, 2020

Time Title Presenter/Authors Session
9:50 AM - 10:00 AM 3444 - Intratumor regulatory T cells prevent IFN-gamma-dependent tumor vessel regression and can be selectively targeted by anti-CD25 near-infrared photoimmunotherapy Yutaka Kurebayashi, M.D., Ph.D., Molecular Imaging Program MS.TB06.01 - Innovative Approaches and Tools to Study the Tumor Microenvironment
10:05 AM - 10:15 AM 3445 - Immuno-transcriptomic profiling identifies actionable genomic alterations in pediatric solid malignancies Javed Khan, M.D., Genetics Branch MS.TB06.01 - Innovative Approaches and Tools to Study the Tumor Microenvironment
10:20 AM - 10:30 AM 3431 - Epigenetic reactivation of the DLC1 tumor suppressor protein is a new approach for cancer treatment Brajendra K. Tripathi, Ph.D., Laboratory of Cellular Oncology

MS.MCB03.01 - Novel Mechanisms: From Tumor Suppression to Identification of Novel Therapeutics

12:00 PM - 12:45 PM Awardee, AACR-Women in Cancer Research Charlotte Friend Lectureship Patricia Steeg, Ph.D., Women's Malignancies Branch LE06 - AACR-Women in Cancer Research Charlotte Friend Lectureship
12:50 PM - 1:30 PM Awardee, AACR-Cancer Research Institute Lloyd J. Old Award in Cancer Immunology Steve Rosenberg, M.D., Ph.D., Surgery Branch LE09 - AACR-Cancer Research Institute Lloyd J. Old Award in Cancer Immunology